The aim of the current study was to describe an integrative analysis of HER2 and ATM interaction using the Cancer Genome Atlas (TCGA) bladder cancer cohorts to highlight the importance of both genes as potential prognosticators for bladder cancer patients. The gene discussed is ERBB2; the disease is urinary bladder cancer.